Lakefront Biotherapeutics NV (AMS:LKFT)

AMS:LKFT Revenue

Lakefront Biotherapeutics NV had revenue of 13.66M EUR in the quarter ending June 30, 2026, a decrease of -81.44%. This brings the company's revenue in the last twelve months to 1.05B, up 232.63% year-over-year. In the year 2025, Lakefront Biotherapeutics NV had annual revenue of 1.17B with 268.41% growth.

• Revenue (ttm): 1.05B
• Revenue Growth: +232.63%
• P/S Ratio: 1.59
• Revenue / Employee: 2.19M
• Employees: 452
• Market Cap: 1.57B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	849.32M	268.41%
Dec 31, 2024	316.42M	29.43M	10.25%
Dec 31, 2023	287.00M	9.62M	3.47%
Dec 31, 2022	277.38M	-3.08M	-1.10%
Dec 31, 2021	280.46M	-249.81M	-47.11%
Dec 31, 2020	530.26M	-355.54M	-40.14%
Dec 31, 2019	885.80M	578.13M	187.91%
Dec 31, 2018	307.67M	151.75M	97.33%
Dec 31, 2017	155.92M	4.31M	2.84%
Dec 31, 2016	151.61M	91.03M	150.27%
Dec 31, 2015	60.58M	-29.44M	-32.70%
Dec 31, 2014	90.02M	-6.55M	-6.78%
Dec 31, 2013	96.57M	4.35M	4.71%
Dec 31, 2012	92.23M	-23.06M	-20.01%
Dec 31, 2011	115.29M	-21.27M	-15.57%
Dec 31, 2010	136.56M	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error